Answers are grounded in this paper and cite their sources.
Demonstrates potent and selective activation of 5-HT4 receptors using a novel indole-carbazimidamide agonist in guinea pig tissue, highlighting a new pharmacophore map for targeted drug design.
The design and synthesis of a new class of potent and selective 5-HT4 receptor agonists containing an indole nucleus linked to a carbazimidamide are presented. A conformational study of the 5-HT4 receptor agonists serotonin and zacopride led to the identification of an initial pharmacophore and to the definition of a three-dimensional map of the 5-HT4 agonist recognition site. 1, a representative member of our new class of 5-HT4 receptor agonists, incorporates all reference structural features and matched perfectly with these models. 1 is a highly potent, full agonist at 5-HT4 receptors present in the isolated electrically stimulated guinea pig ileum preparation, with a pD2 value of 8.8, displaying selectivity (ranging from 40- to over 10,000-fold) versus other members of the serotonin receptor family.
No takes yet. Share an insight, caveat, or question.
Buchheit et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: